NOVAVAX INC Total Long-Term Debt
NOVAVAX INC (NVAX) had Total Long-Term Debt of $291.49 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-08-06
- 2026-06-30: Long-term Debt $291.49M.
- 2026-03-31: Long-term Debt $291.04M.
- 2025-12-31: Long-term Debt $244.21M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $291.49M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $291.04M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $244.21M 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |